Anisley Valenciaga

ORCID: 0000-0003-0600-3918
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related Molecular Pathways
  • Medical Imaging and Pathology Studies
  • Parathyroid Disorders and Treatments
  • Thyroid Cancer Diagnosis and Treatment
  • Genetic Syndromes and Imprinting
  • Calpain Protease Function and Regulation
  • S100 Proteins and Annexins
  • Advanced Breast Cancer Therapies
  • Radiology practices and education
  • Cardiac tumors and thrombi
  • Chromatin Remodeling and Cancer
  • Ultrasound in Clinical Applications
  • Sarcoma Diagnosis and Treatment
  • Clusterin in disease pathology
  • Ear and Head Tumors
  • Radiation Dose and Imaging
  • Congenital heart defects research

The Ohio State University
2021-2025

The Ohio State University Wexner Medical Center
2017-2024

Background: Medullary thyroid cancer (MTC) is a frequently metastatic tumor of the that develops from malignant transformation C-cells. These tumors most commonly have activating mutations within RET or RAS proto-oncogenes. Germline result in C-cell hyperplasia, and cause MTC pre-disposition disorder, multiple endocrine neoplasia, type 2A (MEN2A). Single-agent therapies for MTC, including vandetanib (VAN) cabozantinib all MTCs selpercatinib (SEL) RET-mutated lead to partial responses but are...

10.1089/thy.2024.0102 article EN Thyroid 2025-01-27

Metastatic medullary thyroid cancer (MTC) is incurable and FDA-approved kinase inhibitors that include oncogenic RET as a target do not result in complete responses. Association studies of human MTCs murine models suggest the CDK/RB pathway may be an alternative target. The objective this study was to determine if CDKs represent therapeutic targets for MTC define mechanisms activity. Using cells are either sensitive or resistant vandetanib, we demonstrate palbociclib (CDK4/6 inhibitor)...

10.1172/jci.insight.122225 article EN JCI Insight 2018-08-22

Background: The retinoblastoma (RB) transcriptional corepressor 1 protein functions to slow cell-cycle progression. Inactivation of RB by reduced expression and/or hyperphosphorylation allow for enhanced progression through the cell cycle. Murine models develop medullary thyroid carcinoma (MTC) after generalized loss RB. However, in MTC has only been evaluated a small number tumors, with differing results. objective this study was determine whether overexpression hyperphosphorylated predict...

10.1089/thy.2017.0113 article EN Thyroid 2017-11-04

Pleomorphic liposarcoma of the uterus (PLU) is an extremely rare disease with poor prognosis. Limited treatment options exist for these patients, and recurrence usually occurs rapidly within months initial diagnosis. Few case reports metastatic PLU are available in literature. We describe a 70-year-old woman who presented large ovarian mass on imaging negative serum tumor markers endometrial biopsy. Staging revealed localized disease. Surgical resection pathology. Immunohistochemistry was...

10.6004/jnccn.2021.7039 article EN Journal of the National Comprehensive Cancer Network 2021-07-01

As ultrasound has gained popularity with improving technology and ease-of-use, a push been made to integrate into the medical school curriculum. Many institutions are reporting one- four-year integrated curricula augment anatomy pathophysiology teaching. Our goal was thyroid scanning session endocrinology block of our institution’s curriculum enhance student understanding pathophysiology. We conducted prospective, single-center cohort (pre-experimental) study evaluate performance knowledge...

10.7759/cureus.12421 article EN Cureus 2021-01-01

Abstract Disclosure: A. Valenciaga: None. M.N. Rayan: S.W. Ing: Background: Parathyromatosis is a rare cause of hyperparathyroidism. It refers to numerous parathyroid tissue foci within the neck and mediastinum, arising from expansion embryologic or due dissemination cells during surgical resection abnormal glands. Here, we describe case patient who underwent multiple medical interventions manage recurrent hyperparathyroidism secondary parathyromatosis. Clinical Case: A 28-year-old male with...

10.1210/jendso/bvae163.489 article EN cc-by-nc-nd Journal of the Endocrine Society 2024-10-01

Abstract Hypoparathyroidism (hypoPTH), sensorineural deafness, and renal dysplasia (HDR) syndrome is a rare autosomal dominant condition with approximately 200 cases published. HDR caused by variants of GATA binding protein 3 gene (GATA3), which encodes transcription factor, multiple types GATA3 reported. We present the case 76-year-old woman who was diagnosed hypoPTH when she aged 40 years transferred care to our institution. Further history elucidated presence deafness at age 1 year...

10.1210/jcemcr/luae246 article EN cc-by-nc-nd JCEM Case Reports 2024-12-12

Ectopic parathyroid glands are not rare. They usually located between the mandible and mediastinum, localized with standard imaging modalities (99mTc-sestamibi subtraction scintigraphy 4D-CT). We report case of a 67-year-old woman severe hypercalcemia due to symptomatic primary hyperparathyroidism whose preoperative 99mTc-sestamibi 4D-CT scans were non-localizing. During 4-gland exploration, one hypercellular was excised, two normocellular parathyroids biopsied, bilateral low internal...

10.1016/j.jecr.2022.100119 article EN cc-by-nc-nd Journal of Clinical and Translational Endocrinology Case Reports 2022-05-24
Coming Soon ...